Other OTC - Delayed Quote USD

G Medical Innovations Holdings Ltd (GMVDF)

0.0120 +0.0019 (+18.81%)
At close: May 15 at 2:07 PM EDT
Loading Chart for GMVDF
DELL
  • Previous Close 0.0101
  • Open 0.0100
  • Bid --
  • Ask --
  • Day's Range 0.0100 - 0.0140
  • 52 Week Range 0.0060 - 0.5200
  • Volume 4,398
  • Avg. Volume 33,391
  • Market Cap (intraday) 3.119M
  • Beta (5Y Monthly) -1.14
  • PE Ratio (TTM) --
  • EPS (TTM) -18.7600
  • Earnings Date May 16, 2024 - May 19, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.

gmedinnovations.com

84

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GMVDF

Performance Overview: GMVDF

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GMVDF
45.45%
S&P 500
11.29%

1-Year Return

GMVDF
97.13%
S&P 500
28.71%

3-Year Return

GMVDF
--
S&P 500
24.00%

5-Year Return

GMVDF
--
S&P 500
24.00%

Compare To: GMVDF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GMVDF

Valuation Measures

Annual
As of 5/14/2024
  • Market Cap

    338.12k

  • Enterprise Value

    2.14M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.00

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.48

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -223.32%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    4.42M

  • Net Income Avi to Common (ttm)

    -13.52M

  • Diluted EPS (ttm)

    -18.7600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    295k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -4.87M

Research Analysis: GMVDF

Company Insights: GMVDF

Research Reports: GMVDF

People Also Watch